Matrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued 5/28/2009, EIR signed 5/27/2005, and 483 issued 5/27/2005 (23 pages)

Unapproved New Drugs/Misbranded/Botox

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program.

Learn about the warnings for weight loss products that contain hidden drugs and other hidden ingredients.

Join us for the 2025 Advancing Generic Drug Development Workshop! FDA experts will demonstrate the FDA’s Generic Drug User Fee Amendments (GDUFA) Science and Research Program’s transformative impact on generic drug development, regulation, and approval.

The Compounding Quality Center of Excellence’s free in-person training programs target outsourcing facility staff and offer continuing education credits. The training will open for state regulators and pharmacy compounders if space is available.

Navitas Organics is voluntarily recalling select lots of its 8oz Organic Chia Seeds due to possible Salmonella contamination. This recall is being conducted as a precautionary measure following a recall initiated by the company’s chia seed supplier.